GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review. // Disease-A-Month. – URL: https://www.sciencedirect.com/science/article/pii/S001150292600088X?dgcid=rss_sd_all
GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review. Disease-A-Month. https://www.sciencedirect.com/science/article/pii/S001150292600088X?dgcid=rss_sd_all
“GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.” Disease-A-Month.
@article{article43478,
title = {GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review},
journal = {Disease-A-Month},
url = {https://www.sciencedirect.com/science/article/pii/S001150292600088X?dgcid=rss_sd_all}
}